Board Composition Change definition

Board Composition Change means the occurrence of a change in the Board of Directors of the Company in which the individuals who constituted the Board of Directors of the Company at the beginning of the two-year period immediately preceding such change (together with any other director whose election by the Board of Directors of the Company or whose nomination for election by the stockholders of the Company was approved by a vote of a majority of the directors then in office either who were directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority of the directors then in office.
Sample 1Sample 2Sample 3
Board Composition Change shall occur at such time that none of the Disinterested Directors who serve on the Company's Board of Directors as of the Effective Date continue to serve in such capacity.
Sample 1

Examples of Board Composition Change in a sentence

  • One translation, on which he based his comparison with other techniques, precluded maximum parallelism among transi- tions (that is, some simultaneously enabled non-conflicting transitions are not allowed to be taken simultaneously and have to be taken in sequence), and therefore might not be op- timal for symbolic model checking.

  • Local Governance Policy (01-2014) Version 003, July 2014; Workforce System Guidance 01- 2015, Local Board Composition, Change 1, May 28, 2015; Workforce System Guidance 01-2014, Composition of Pennsylvania’s Local Workforce Development Boards—Initial Implementation of the Workforce Innovation and Opportunity Act of 2014, March 1, 2014; Workforce Investment Information Notice No. 2-03, Change 1, Local Workforce Investment Board Staffing Policy.

  • Board Composition Change and Creation of Dispensing Optician CommitteeThis bill would replace one optometrist member with one RDO.

  • Transportation Issues – 1:05 pmn Meeting re: Metro Board Composition Change Proposals – Kurt Weideman –GARCETTI COULDN’T ATTEND SO MEETING CANCELLED.n Measure M updaten Advisory Council composition changed to add one non-elected official representative for each COG – WEIDEMAN/GOODHART – BACHARACH/LANTZROBLES LETTER RE: METRO LABOR AGREEMENT – yellow in packetn NEW METRO BOARD MEMBER – DIANE DUBOIS REPRESENTING GATEWAY COG DID NOT RUN FOR RE-ELECTION TO THE METRO BOARD.

  • Upon further examination of the data, we found that a large percentage of organizations provided no director compensation; therefore, the large zero base-rate attenuated the correlations.Table 3-Results of Director Compensation on Board Composition Change in Number of Outside Directors Statistical Tests Annual RetainerMean Std.

  • Except as specified in Section 4.2 below, during the term of this Agreement Providence shall be responsible for and shall pay all administrative costs and professional fees associated with activities conducted pursuant to the terms of this Agreement by Xxxxxxx’x office staff and professional consultants.

  • The Plan Administrator may, in its sole discretion, amend or discontinue this Plan or the benefits provided hereunder at any time prior to the occurrence of a Transaction or a Board Composition Change.

  • Notwithstanding the foregoing, in the event a Board Composition Change occurs, an Eligible Executive Officer will be eligible to receive Retention Benefits under this Plan even if he is not so employed upon the occurrence of a Change in Control, as long as he was employed by the Company immediately prior to such Board Composition Change.

  • This Court concludes that the offense involved sophisticated means.

  • The evidence obtained by the House Oversight Committee further suggests that President Trump’s personal attorney Ms. Dillon and his White House attorney Mr. Passantino misled OGE in March, April, and May 2018 about monies owed to Mr. Cohen in an apparent attempt to keep the transaction hidden from public view.

Related to Board Composition Change

  • Board Change means, during any period of two consecutive years, individuals who at the beginning of such period constituted the entire Board cease for any reason to constitute a majority thereof unless the election, or the nomination for election, of each new director was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of the period.

  • Licensed Compound means [***].

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Active Ingredient means the clinically active material(s) that provide pharmacological activity in a pharmaceutical product (excluding formulation components such as coatings, stabilizers, excipients or solvents, adjuvants or controlled release technologies).

  • Control device means equipment (such as an incinerator or carbon adsorber) used to reduce, by destruction or removal, the amount of air contaminants in an air stream prior to discharge to the ambient air.

  • Non-Microsoft Product means any third-party-branded software, data, service, website or product, unless incorporated by Microsoft in a Product.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Peer-reviewed medical literature means a published scientific study in a journal or other publication in which original manuscripts have been published only after having been critically reviewed for scientific accuracy, validity and reliability by unbiased independent experts, and that has been determined by the international committee of medical journal editors to have met the uniform requirements for manuscripts submitted to biomedical journals. Peer-reviewed medical literature does not include publications or supplements to publications that are sponsored to a significant extent by a pharmaceutical manufacturing company or health carrier.

  • COVID-19 Pandemic means the SARS-Cov2 or COVID-19 pandemic, including any future resurgence or evolutions or mutations thereof and/or any related or associated disease outbreaks, epidemics and/or pandemics.

  • Common Channel Signaling (“CCS”) is a method of digitally transmitting call set-up and network control data over a digital signaling network fully separate from the public switched telephone network that carries the actual call.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.